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Abstract objectives To achieve UNAIDS 90-90-90 targets, alternatives to conventional HIV testing models
are necessary in South Africa to increase population awareness of their HIV status. One of the
alternatives is oral mucosal transudates-based HIV self-testing (OralST). This study describes
implementation of counsellor-introduced supervised OralST in a high HIV prevalent rural area.
methods Cross-sectional study conducted in two government-run primary healthcare clinics and
three Medecins Sans Frontieres-run fixed-testing sites in uMlalazi municipality, KwaZulu-Natal. Lay
counsellors sampled and recruited eligible participants, sought informed consent and demonstrated
the use of the OraQuickTM OralST. The participants used the OraQuickTM in front of the counsellor
and underwent a blood-based DetermineTM and a UnigoldTM rapid diagnostic test as gold standard for
comparison. Primary outcomes were user error rates, inter-rater agreement, sensitivity, specificity and
predictive values.
results A total of 2198 participants used the OraQuickTM, of which 1005 were recruited at the
primary healthcare clinics. Of the total, 1457 (66.3%) were women. Only two participants had to
repeat their OraQuickTM. Inter-rater agreement was 99.8% (Kappa 0.9925). Sensitivity for the OralST
was 98.7% (95% CI 96.8–99.6), and specificity was 100% (95% CI 99.8–100).
conclusion This study demonstrates high inter-rater agreement, and high accuracy of supervised
OralST. OralST has the potential to increase uptake of HIV testing and could be offered at clinics
and community testing sites in rural South Africa. Further research is necessary on the potential of
unsupervised OralST to increase HIV status awareness and linkage to care.
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Introduction
Availability of and access to free, confidential and
accurate testing services is the first stage in achieving
the UNAIDS 2020 targets of having 90% of the HIV-
infected population aware of their status, 90% of these
started on antiretroviral and 90% of those treated with
a suppressed viral load [1]. Current HIV counselling
and testing (HCT) strategies are insufficient to achieve
universal HIV status awareness [1, 2]. Innovative alter-
natives to provider and client-initiated HCT models
which increase HCT uptake are a public health impera-
tive [1].
South Africa’s HIV prevalence, estimated at 12.2%
in 2012, is among the highest in the world [3].
According to the 2012 National HIV Prevalence Sur-
vey, only 65.5% of the adult population had ever
tested for HIV [3]. Among the 28 997 participants in
this survey, 62.2% of HIV-positive males and 45.0%
of HIV-positive females were not aware of their status
[3]. To achieve the 90-90-90 objectives, the Department
of Health of South Africa aimed to increase efforts to
expand HCT strategies both at public healthcare facili-
ties and at the community level [4]. However, there
are barriers to overcome (e.g. ensuring that HCT ser-
vices are safe and confidential; the financial and time
investment required by patients) which cannot be com-
pletely eliminated in the context of HCT. Current HCT
models have facilitated access to HIV care to a large
number of people [5], however, some populations,
including both men and women, may benefit from new
models which enable them to test in private at their
own convenience [6].
HIV self-testing involves the self-administration of an
HIV test in any private and convenient place with or
without the guidance of a third party such as a healthcare
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worker. Unsupervised or ‘home’ self-testing (HomeST)
has been shown to be an acceptable innovation in a vari-
ety of settings for individuals to overcome barriers to
HCT [7–9]. Easy access to HomeST might increase test-
ing uptake among key populations such as men who have
sex with men and commercial sex workers who fear
stigma, discrimination and breaches in confidentiality [7].
Among the HIV self-testing modalities, oral mucosal
transudates-based self-testing kits (OralST) are less inva-
sive than blood-based kits and are more easily self-admi-
nistered [2, 9]. An O-HIVST device available in South
Africa is the OraQuick ADVANCE HIV 1/2 Rapid Anti-
body Test (TMOrasure Technologies Inc., Bethlehem, PA,
USA). Accuracy studies have been conducted in Zambia
and Malawi, where OraQuickTM showed a sensitivity of
98.7% (95% CI: 97.5–99.4) and 93.6% (95% CI: 88.2–
97.0), with specificity of 99.8% (95% CI: 99.6–99.9) and
99.9% (95% CI: 99.6–100), respectively [10, 11]. A
meta-analysis identified, in high-prevalence settings, a
pooled sensitivity 2% lower in oral-based specimens than
in blood-based specimens alongside similar specificity and
positive predictive values [12].
In South Africa, self-testing devices are not prohib-
ited by current legislation. While the Department of
Health of South Africa does not recommend their use
[13], the Pharmacy Council of South Africa has
recently removed the ban on pharmacists’ sales of self-
testing kits [14]. The main concerns around self-testing
include user errors, incorrect interpretation of results,
potential self-harm following a positive self-test result,
potentially increased risks of coercion and missed
opportunities for confirmatory testing and linkage to
care [2, 7–9, 15].
In a recent cross-sectional study in South Africa,
22.3% of participants reported that they would prefer
HomeST over provider and client-initiated HCT
(n = 466) [16]. A study in KwaZulu-Natal reported high
accuracy in reading results and high compliance with
blood-based self-testing procedures in a supervised envi-
ronment [17]. Another usability study reported higher
acceptability of home OralST compared with home
blood-based self-testing [18]. Health personnel using
home OralST reported high acceptability and potential
for linkage to care in another study in Cape Town [19].
More evidence on the implementation of self-testing
under field conditions is crucial. The purpose of this
study was to describe implementation of supervised
OralST in a high HIV prevalence rural area. The specific
aim of this article was to determine whether it is feasible
for participants to correctly perform, read and interpret
an OralST under counsellor supervision and the diagnos-
tic accuracy of OralST.
Methods
This study was prospective cross-sectional, and its con-
duct was preceded by a formative assessment using quali-
tative methodologies [20]. OralST was offered at two
Department of Health-run primary healthcare clinics
(PHCs), between June and December 2014. OralST was
then offered at three Medecins Sans Frontieres (MSF)-run
fixed HIV testing sites (FTSs) in Eshowe town between
November 2014 and April 2015. The FTSs are stand-
alone health posts staffed by lay HIV counsellors where
any community member can receive HCT, point-of-care
CD4 testing, and STI, TB and pregnancy screening. All
study sites were in the rural uMlalazi municipality (popu-
lation 231 601), in KwaZulu-Natal province. The overall
HIV prevalence in the study area was 15.9% in men and
30.9% in women according to a cross-sectional survey
conducted in 2012 (n = 5649) [21]. According to this
survey, HIV prevalence peaked at 56% among women
aged 30–35 years [21].
Sampling and recruitment
All PHC and FTS clients who were at least 18 years of
age and willing to give written informed consent were eli-
gible to participate. Clients with dentures, who had eaten
or drunk anything or who had brushed their teeth, used
mouthwash or flossed within 30 min of conducting the
OralST were excluded. Clients could wait and enrol once
they were eligible to do so. Individuals who were known
to be HIV infected were eligible.
Recruitment strategies were designed to suit the con-
text of the two types of study site. At the FTSs, com-
munity mobilisers announced the study to street
passers-by to attract potential participants. At the
PHCs, research counsellors announced the study in the
waiting area and invited all clinic users to participate.
In both FTSs and PHCs, individuals who expressed
interest in the study were screened for eligibility and
enrolled in the private spaces used to conduct HCT.
Across all sites, the research counsellors obtained
informed consent, demonstrated and supervised the use
of the OralST to consenting participants and provided
pre- and post-test counselling.
Testing algorithm
The counsellors explained the OralST procedure to
each participant individually and demonstrated how to
conduct the OraQuickTM test (TMOrasure Technologies
Inc.) according to the manufacturer’s package instruc-
tions. Following the demonstration, the participants
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first self-tested in front of the counsellor, and immedi-
ately afterwards, they received a blood-based Determine
rapid test (TMAlere, Scarborough, ME, USA) (Figure 1).
As per OraQuickTM procedures, participants could read
the result in the period 20–40 min after the test. The
participant’s reading was then verified by the counsel-
lor, and agreement or disagreement between the two
was noted.
All participants who had an HIV-positive Deter-
mineTM result received confirmatory testing using a
blood-based Unigold rapid test (TMTrinity Biotech, Bray,
Co., Wicklow, Ireland). If the HIV infection diagnosis
was confirmed, the participants were linked to HIV
care at their preferred clinic. If the HIV testing result
was indeterminate, the participants were referred for
repeated testing.
Sample size
We calculated the sample size required to demonstrate
with 95% confidence the true sensitivity, to a precision
of 5%, to be 1000 people at the PHCs and 1000 at the
FTSs.
Data management
Information that related to the participants’ demograph-
ics and to the OralST and confirmatory test results was
manually collected onsite in a paper register. All docu-
ments – consent forms and registers – were returned daily
by the counsellors to the MSF office in Eshowe.
The data from the registers were captured into an Epi-
Data database (TMEpidata Foreningen, Odense, Denmark).
Univariable and bivariable descriptive analyses were con-
ducted using STATA 11 (TMStataCorp, College Station,
TX, USA).
Measurement and analysis
The ability of participants to correctly perform, read and
interpret the results of OralST was assessed by determining
the user error rate (number of tests repeated as a result of
user error/total number of tests) and the inter-rater agree-
ment (participant vs. counsellor) of OralST result. The
Kappa statistic was used to establish statistical significance
in inter-rater agreement of reading OralST results.
The diagnostic accuracy of OralST was assessed by cal-
culating sensitivity, specificity and positive and negative
predictive values using the DetermineTM and the
UnigoldTM results as the gold standard. Sensitivity and
specificity were reported with 95% CIs. X2 tests were
used to assess statistical differences in categorical out-
comes such as uptake of the OralST between groups
stratified by sex, site and recent HIV testing.
Uptake of OralST in the framework of this study was
approximated by assessing the proportion of those who
participated among those who were eligible. Uptake was
calculated by determining the proportion of participants
out of (i) the clinic users’ headcount in the waiting room
at the PHCs and (ii) the daily attendance registers (i.e.
the numbers tested under the routine client-initiated
















peated TestingFigure 1 Testing algorithm used in this
study.
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Ethics
At point of recruitment, written informed consent was
sought for each participant in the same private place
where all research procedures were conducted. A signed
copy of the information sheet and informed consent was
handed to each participant. This study received ethical
approval from the Human Research Ethical Committee
of the University of Cape Town (Cape Town, South
Africa) and from the KwaZulu-Natal Department of
Health (Pietermaritzburg, South Africa).
Results
Uptake
A total of 2205 participants completed the OraQuickTM.
Seven participants were excluded from the analysis as
they did not receive a DetermineTM test (Figure 2). In
total, 1457 (66.3%) women and 741 (33.7%) men were
included in the analysis (Table 1).
At the FTSs, 1193 participants (54.1%) were recruited.
At the PHCs, 1005 participants (45.7%) were recruited.
With regard to the FTSs, 29.6% of men and 35.9% of
the women approached consented to participate. Com-
pared to the headcount, uptake of OralST was 25.4% for
the two PHCs (headcount at the PHCs did not differenti-
ate between men and women).
The ages of male and female participants were similar.
The median age of men was 27 years (IQR 22–34) and
of women 28 years (IQR 22–36). Overall, 1397 female
participants (95.8% of total women) and 671 male
(83.2% of total men) had tested for HIV before, and 74
women (5.1%) and 29 men (3.9%) had heard about
OralST before the study (Table 2). Among the 70 men
and 60 women who had never tested before but who
used the OraQuickTM, 30 men (42.8%) and 29 women
(48.3%) were in the 18–25 years age group.
Feasibility: inter-rater agreement and user error rate
As an indicator of feasibility of supervised OralST, inter-
rater agreement between counsellor’s and participant’s
reading of the OraQuickTM was calculated excluding 11
women and six men who were known HIV infected
(Table 3). Of 2181 participants who were unaware of
their status, there was disagreement on four tests; three
women and one man read their OraQuickTM result as
negative while the counsellor read the result as positive.
Thus, overall inter-rater agreement was 99.8% (Kappa
0.9925).
Another measurement of feasibility was the rate of user
errors. The OraQuickTM was correctly performed by 2196
users (user error rate 0.09%). Only two participants – a
woman and a man – had to repeat their self-test because,
accidentally, they spilled the developer solution vial.
Accuracy
Specificity and sensitivity were calculated using the results
of all OraQuickTM as read by the participants and the
DetermineTM and UnigoldTM test results (Table 4). Eleven
indeterminate results were excluded from the accuracy
analysis. In this study, the sensitivity and specificity of
the OralST test were high at both PHCs and FTSs (data



































Figure 2 Testing flow in the study.
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98.7% (95% CI 96.8–99.6) and specificity was 100.0%
(95% CI 99.8–100). Positive and negative predictive
values were also high with values set at 100.0% (95%
CI 98.2–99.9) and 99.7% (95% CI 99.4–99.9),
respectively.
HIV prevalence
Fifteen (6.2%) of the 248 HIV-infected women and
two (0.6%) of the 89 HIV-infected men in this study
were known HIV positive. Excluding these 17
participants, the HIV prevalence in this study was
14.7% (95% CI; 13.2–16.2): 10.6% (95% CI;
13.1–16.1) were women and 3.9% (95% CI: 3.1–4.8)
were men.
Eighty women and 34 men received their first HIV
diagnosis at the FTSs (Table 5). Forty (50%) of these 80
women were in the age group 18–25 years, and 21
(61.7%) of these 34 men were in the age group 26–
35 years. Another 153 women and 53 men received their
first HIV diagnosis at the PHCs. Seventy-eight (50.9%)
of these 153 women were in the age group 18–25 years,




TotalSex Men Women Subtotal Men Women Subtotal







3955 3955 1623 1979 3602 7557
Uptake 25.4% 25.4% 29.6% 35.9% 33.1% 29.1%
*Based on the headcount in the clinic waiting areas, and on the number of clients regis-
tered at the FTSs. Headcount at the PHCs did not differentiate between men and
women.
Table 2 History of HIV testing and
knowledge of OralST stratified by age
and sex
Age
Ever tested for HIV (n = 2068/2198) Ever heard of OralST (n = 103/2198)
Women† Men† P-value* Women‡ Men‡ P-value*
18–25 784 (56.1%) 302 (45.0%) <0.001 49 (66.2%) 10 (34.5%) 0.049
26–35 338 (24.2%) 211 (31.4%) 19 (25.7%) 16 (55.2%)
36–45 134 (9.6%) 75 (11.2%) 3 (4.0%) 1 (3.4%)
46–55 75 (5.4%) 41 (6.1%) 2 (2.7%) 1 (3.4%)
56+ 66 (4.7%) 42 (6.2%) 1 (1.3%) 1 (3.4%)
Total 1397 (100%) 671 (100%) 74 (100%) 29 (100%)
*Chi-squared test (P < 0.05).
†Denominator: Total number of participants who had ever tested for HIV by sex.
‡Denominator: Total number of participants who had ever heard of self-testing by sex.
Table 3 Inter-rater agreement at both





Counsellor Negative 1870 (85.7%) 0 (0.0%) 1870 (85.7%) 99.8% Agreement
Counsellor Positive 4 (0.2%) 307 (14.1%) 311 (14.2%) 0.9925 Kappa
Subtotal 1874 (85.9%) 307 (14.1%) 2181 (100%)
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and 24 (45.2%) of these 53 men were in the age group
26–35 years.
Discussion
This cross-sectional study demonstrates high inter-rater
agreement (99.8%) and high accuracy (sensitivity 98.7%;
specificity 100.0%) of counsellor-introduced, supervised
OralST in rural South Africa. User error rate (0.09%)
was negligible as only two self-tests were repeated.
This study contributes to evidence provided by previ-
ous research in the Southern Africa region on the feasibil-
ity, under field conditions, of oral-based self-testing [19].
This study is consistent with previous research on the
accuracy of counsellor-introduced and supervised Ora-
QuickTM in Zambia and in Malawi that reported sensitivi-
ties of 98.7 (95% CI 97.5–99.4) and 97.7 (95% CI 87.9–
100) with specificities of 99.8 (95% CI, 99.6–99.9) and
100 (95% CI 97.8–100), respectively [10, 11].
Building on this and provided that instructions are in
local languages and adapted for cultural appropriateness
[17], it is reasonable to hypothesise that accuracy of
OralST for unsupervised use could also be high in rural
KwaZulu-Natal. Although the user error rates in our
study were low, we did not explore the types of errors
that clients might make if they conducted the Ora-
QuickTM OralST in the absence of a counsellor. There-
fore, the generalisability of these results to home based or
unsupervised OralST needs to be further explored.
In spite of high accuracy, it must be noted that four-
teen of our 2198 study participants read their Ora-
QuickTM as negative but had a positive DetermineTM test.
There are several different oral rapid diagnostics devices
currently available commercially; however, many of them
have not yet been pre-qualified by WHO for self-testing
[22]. It must be noted that most research on accuracy of
OralST devices carried out in Southern Africa used an











323 0 323 1 324
OralST
Negative
4 1860 1864 10 1874
Subtotal 327 1860 2187 11 2198
Accuracy Sensitivity 98.7% (95% CI 96.8–99.6)
Specificity 100.0% (95% CI 99.8–100)
PPV 100.0% (95% CI 98.2–99.9)
NPV 99.7 (95% CI 99.4–99.9)
*This analysis considers the OraQuickTM results as read by the participants.
†In this sensitivity and specificity analysis, eleven (11) indeterminate and unconfirmed
results are excluded.
NPV, Negative predictive value; PPV, Positive predictive value.
Table 4 Accuracy: sensitivity, specificity,
negative predictive value and positive pre-
dictive values
Table 5 First HIV+ diagnosis per site
Age
Fixed-testing sites Primary healthcare clinics
Women Men Subtotal P-value* Women Men Subtotal P-value*
18–25 40 6 46 (40.3%) 0.015 78 8 86 (41.7%) <0.001
26–35 31 21 52 (45.6%) 49 24 73 (35.4%)
36–45 5 4 9 (7.9%) 16 13 29 (14.1%)
46–55 4 3 7 (6.1%) 7 6 13 (6.3%)
56+ 0 0 – 3 2 5 (2.4%)
Total 80 (70.2%) 34 (29.8%) 114 (100.0%) 153 (74.3%) 53 (25.7%) 206 (100%)
Note: excludes 17 participants who were known HIV+.
*Chi-squared test (P < 0.05).
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available OralST devices in necessary [10–12, 23]. It is
important to understand available devices, particularly
with respect to a shorter window period. Ideally a device
which detects p24 protein to establish acute HIV infec-
tion is desirable. The importance of receiving a confirma-
tory HIV test will need be emphasised to all users of an
OralST in an unsupervised environment.
The strength of this study is its large sample size,
which allowed assessing accuracy with high precision.
Data on socio-demographics and other variables of inter-
est such as engagement in risky sexual behaviours, uptake
of HIV prevention technologies, frequency of retesting
and most recent date of testing were not collected. In this
regard, a more detailed description of the participants
and a comparison of the characteristics of the partici-
pants with other studies on self-testing in the region are
not possible.
A limitation of this study might be the uptake rates of
OralST at the MSF-run FTSs (33.1%) and at the Depart-
ment of Health-run PHCs (26%). Although these uptake
rates seem low, we consider them acceptable due to the
sampling and recruitment methods used. It needs to be
noted that the OralST was offered on weekdays at
healthcare posts where many users had arrived to
demand services others than HIV testing.
Future prospects
This study was preceded by a formative assessment using
qualitative methodologies [20]. Female and male PHCs
clients were interviewed, many of whom claimed that
men and youth could benefit from the privacy and confi-
dentiality of using a home OralST. These findings coin-
cided with other qualitative research on acceptability of
home OralST conducted among community members and
healthcare workers in a MSF-run health post in the infor-
mal settlement of Khayelitsha, Cape Town [24].
Our study was not powered to allow a gendered analy-
sis, and therefore, we cannot corroborate findings from
previous qualitative research in South Africa. Neverthe-
less, our results suggest that both women and men might
access and demand OralST. In our study, 35.9% and
29.6% of approached women and men, respectively, used
an OralST at the FTSs in Eshowe. Half of the partici-
pants comprised young adults in age group 18–25 years
and among these, one-third (33.7%) were men. Women
who face time constraints and social and financial barri-
ers to demand clinic-based HCT services may benefit
from easy access to OralST devices.
Our findings support previous research on men using
self-tests when available to them. In a cross-sectional
study in Ethiopia (n = 307), 67% of male healthcare
workers reported having ever used a self-test that they
accessed in their workplaces [25]. In multiple countries,
men who have sex with men report the use of OralST
purchased over the counter, on Internet sites or in elec-
tronic vending machines [7, 26]. Future research on
mens’ and young adults’ access to self-testing will need to
focus on monitoring uptake of post-test counselling ser-
vices and linkage to care.
To influence policy in South Africa, more evidence is
necessary on the impact of unsupervised HIVST among
key populations such as men who have sex with men,
commercial sex workers, migrants and prisoners. In
South Africa, men are less aware of their HIV status than
women: a cross-sectional survey conducted in 2005 in
rural KwaZulu-Natal reported that only 18% of sexually
active men 18–32 years old had ever tested [27]. A popu-
lation-based survey conducted by MSF in Eshowe and
Mbongolwane areas in 2013 (n = 5649) identified men
and young people as populations that require targeted
and novel testing strategies, as HIV status awareness was
much lower among them than among women [21]. In
high HIV prevalence contexts such as KwaZulu-Natal, it
is imperative that efforts are pooled to increase testing
among men and youth – and, in general, among key pop-
ulations – as an increase in the proportion of people who
are aware of their HIV status will allow earlier initiation
of ART and may facilitate behaviour change and ulti-
mately decrease HIV transmission.
A sex and gender research approach [28] will be help-
ful to ascertain the validity of the hypothesis that unsu-
pervised HIVST would contribute to an increase in HIV
status awareness. Southern African men might be aware
of mainstream public health recommendations to demand
HCT services but research suggests that they see clinics
as gendered spaces in which they feel unwelcome and
which they avoid because they do not want to be
attended to by female healthcare workers [29]. According
to most recent research on the impact of hegemonic mas-
culinities, gender scripts such as imperviousness, fearless-
ness or invulnerability prevent men from accepting HCT.
Client-initiated HCT therefore contradicts how they act
out their masculinity through toughness, independence
and self-confidence as gendered, condoned characteristics
of men [6, 30]. More research on whether unsupervised
HIVST could be a feasible male-centred model to increase
testing of men is necessary.
Conclusion
In July 2015, WHO released new consolidated guidelines
on HIV testing services and included HIVST as one of
the approaches that could potentially extend HIV testing
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services to people who are reluctant to attend existing
HCT services and to people who frequently retest [31].
The WHO and UNAIDS had previously emphasised the
need to develop a larger evidence base on HIVST to bet-
ter inform national policies and implementation of
HIVST services [32]. This study responds to this need.
This study shows good user compliance with OralST
procedures, inter-rater agreement and accuracy of super-
vised OralST in clinic and community-level testing sites
in rural South Africa. The data suggest that OralST could
be offered at clinics and community testing sites in rural
KwaZulu-Natal. The use of OralST in an unsupervised
environment could be feasible and accurate; however,
instructions should be adapted to the literacy levels of the
population, and users must be encouraged to receive a
confirmatory test. Although further research is needed on
the potential of unsupervised OralST to increase HIV sta-
tus awareness and linkage to care for key populations
that do not access conventional HCT, this study supports
WHO consideration of OralST as an approach to be
implemented alongside other conventional HCT services.
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